FDA OTC labeling regs anticipated this fall, NDMA's Cope tells annual meeting.
This article was originally published in The Tan Sheet
Executive Summary
FDA PROPOSED OTC LABELING REGS EXPECTED THIS FALL, Nonprescription Drug Manufacturers Association President James Cope told the NDMA annual meeting in Colorado Springs May 18-21. Discussing NDMA's OTC labeling proposal during his "Report from Washington," Cope said the association has "a very positive, proactive program here -- it's one that makes sense, it's one that has support, it's one FDA should adopt."